Disclosure Of First-Time Adoption [Text Block]

Sopharma Trading AD - Filing #6022492

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
25,773,000.000 BGN
24,912,000.000 BGN
225,000.000 BGN
50,463,000.000 BGN
84,900,000.000 BGN
797,000.000 BGN
34,276,000.000 BGN
789,000.000 BGN
34,276,000.000 BGN
76,938,000.000 BGN
10,723,000.000 BGN
29,609,000.000 BGN
22,595,000.000 BGN
392,000.000 BGN
76,938,000.000 BGN
34,276,000.000 BGN
2,038,000.000 BGN
21,806,000.000 BGN
75,804,000.000 BGN
395,000.000 BGN
20,585,000.000 BGN
780,000.000 BGN
Comprehensive income
- BGN
- BGN
87,000.000 BGN
8,000.000 BGN
- BGN
7,962,000.000 BGN
8,041,000.000 BGN
11,417,000.000 BGN
11,408,000.000 BGN
- BGN
- BGN
- BGN
- BGN
9,000.000 BGN
Profit (loss)
- BGN
- BGN
- BGN
- BGN
- BGN
8,050,000.000 BGN
8,050,000.000 BGN
11,476,000.000 BGN
11,476,000.000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.